NARI241220P70000
- 14.90
- 0.000.00%
Inari Medical Newsroom
Truist Securities Raises Price Target on Inari Medical to $63 From $50, Keeps Hold Rating
Inari Medical Analyst Ratings
Oppenheimer Initiates Coverage On Inari Medical With Outperform Rating, Announces Price Target of $75
Truist Financial Maintains Inari Medical(NARI.US) With Hold Rating, Maintains Target Price $50
A Quick Look at Today's Ratings for Inari Medical(NARI.US), With a Forecast Between $50 to $74
A Quick Look at Today's Ratings for Inari Medical(NARI.US), With a Forecast Between $48 to $86
Truist Raises Price Target on Inari Medical to $50 From $46, Keeps Hold Rating
Inari Medical Is Maintained at Neutral by Piper Sandler
Inari Medical Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Inari Medical (NARI), Integer Holdings (ITGR) and Universal Health (UHS)
Truist Lowers Price Target on Inari Medical to $46 From $55, Keeps Hold Rating
Inari Medical Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Day One Biopharmaceuticals (DAWN) and Inari Medical (NARI)
Bank of America Securities Remains a Buy on Inari Medical (NARI)
Inari Medical Price Target Announced at $50.00/Share by Stifel
Stifel Initiates Inari Medical(NARI.US) With Hold Rating, Announces Target Price $50
Piper Sandler Maintains Inari Medical(NARI.US) With Hold Rating, Maintains Target Price $50
Piper Sandler Keeps Their Hold Rating on Inari Medical (NARI)
Inari Medical Analyst Ratings
Deutsche Bank Maintains Inari Medical(NARI.US) With Buy Rating, Maintains Target Price $68